Advertisement

Thromboxane-Induced Erk Phosphorylation in Human Aortic Smooth Muscle Cells

  • Carole Gallet
  • Stéphanie Blaie
  • Sylviane Lévy-Toledano
  • Aïda Habib
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 525)

Abstract

GPCRs (G-protein coupled receptor) activation of extracellular signal- regulated kinases (ERK) has been extensively explored the last decade and showed a multitude of intracellular pathways involved including the activation of PKC, Ras, raf-1, etc [1]. Recently, it has been demonstrated that some GPCRs such as the lysophosphatidic acid, thrombin, bombesin and angiotensin receptor can activate ERK through the phosphorylation of the epidermal growth factor (EGF) receptor [[2]]. This was mainly done using selective inhibitors of the tyrosine kinase activity of the EGF receptor such as the tyrphostin AG1478. Also, direct demonstration of the phosphorylation of the receptor of EGF in response to these different ligands has been demonstrated [[3]].

Keywords

Epidermal Growth Factor Receptor Epidermal Growth Factor Vascular Smooth Muscle Cell Lysophosphatidic Acid Epidermal Growth Factor Receptor Activation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 1997; 9:337.PubMedCrossRefGoogle Scholar
  2. 2.
    Zwick E, Hackel PO, Prenzel N, Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci 1999; 20:408.PubMedCrossRefGoogle Scholar
  3. 3.
    Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A, Signal characteristics of G protein-transactivated EGF receptor. Embo J. 1997; 16:7032.PubMedCrossRefGoogle Scholar
  4. 4.
    Armstrong RA, Wilson NH. Aspects of the thromboxane receptor system. Gen Pharmacol 1995; 26:463.PubMedCrossRefGoogle Scholar
  5. 5.
    Jones DA., Benjamin CW, Linsema DA. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades. Mol Pharmacol. 1995; 48:890.PubMedGoogle Scholar
  6. 6.
    Karim S, Berrou E, Levy-Toledano S, Bryckaert M, MacLouf J. Regulatory role of prostaglandin E2 in induction of cyclo-oxygenase-2 by a thromboxane A2 analogue (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells. Biochem J 1997; 326:593.PubMedGoogle Scholar
  7. 7.
    Heeneman S, Haendeler J, Saito Y, Ishida M, Berk BC. Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor b receptor. J Biol Chem 2000; 275:15926.PubMedCrossRefGoogle Scholar
  8. 8.
    Eguchi S, Dempsey PJ, Frank GD, Motley ED, Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 2001; 276:7957.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Carole Gallet
    • 1
  • Stéphanie Blaie
    • 1
  • Sylviane Lévy-Toledano
    • 1
  • Aïda Habib
    • 1
    • 2
  1. 1.Hôpital LariboisièreINSERM U 348ParisFrance
  2. 2.Department of BiochemistryAmerican University of BeirutBeirutLebanon

Personalised recommendations